The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration (Q39125082)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 July 2013
edit
Language Label Description Also known as
English
The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration
scientific article published on 13 July 2013

    Statements

    The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration (English)
    Takashi Nakamura
    Daiki Yamazaki
    Jun Yamauchi
    Hideyoshi Harashima
    13 July 2013
    216-224

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit